PP
LMAT icon

PDT Partners’s LeMaitre Vascular LMAT Stock Holding History

PDT Partners’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,200
Closed -$568K – 564
2026
Q1 		$568K Buy
+5,200
New +$496K 0.03% 408
2025
Q2 		– Sell
-5,913
Closed -$496K – 773
2025
Q1 		$496K Buy
+5,913
New +$550K 0.04% 528
2021
Q4 		– Sell
-16,700
Closed -$887K – 946
2021
Q3 		$887K Buy
16,700
+6,017
+56% +$339K 0.06% 364
2021
Q2 		$652K Sell
10,683
-7,492
-41% -$398K 0.04% 459
2021
Q1 		$887K Buy
18,175
+3,278
+22% +$154K 0.06% 393
2020
Q4 		$603K Buy
14,897
+3,894
+35% +$139K 0.04% 420
2020
Q3 		$358K Buy
+11,003
New +$330K 0.02% 519

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

PDT Partners's LMAT Position: Q2 2026 in Review

PDT Partners sold out of LeMaitre Vascular (LMAT) in Q2 2026, closing a stake of 5,200 shares — an estimated $568K sold.

PDT Partners first reported a position in LMAT in Q3 2020 and held it in 7 quarters. The position peaked at $887K in Q3 2021. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • PDT Partners reported no remaining LeMaitre Vascular position as of Q2 2026 after selling out during the quarter.
  • PDT Partners sold 5,200 LeMaitre Vascular shares in Q2 2026, an estimated $568K.
  • PDT Partners first reported a position in LeMaitre Vascular in Q3 2020 and held it in 7 quarters.
  • PDT Partners's LeMaitre Vascular position peaked at $887K in Q3 2021.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on PDT Partners's 13F filing for Q2 2026, filed 14 Aug 2026.